Survey finds health workers support transparency on payments from pharma companies

About The Authors

9th November 2015 10:31 - Pharmaceutical

A new survey commissioned by the Association of the British Pharmaceutical Industry has discovered that most healthcare workers in the Survey finds health workers support transparency on payments from pharma companiesUnited Kingdom back greater transparency on the payments received by pharmaceutical companies. However, a proportion think that it may make working in the healthcare industry more challenging.

The researchers interviewed 500 individuals who were doctors, nurses, pharmacists and hospital specialists and revealed that 87 per cent believed that payments from pharmaceutical companies to individual healthcare professionals should be transparent. Of those who currently have a relationship with a pharmaceutical company, 69 per cent said that they are likely to grant the companies permission to reveal their payment history.

However, 32 per cent of healthcare workers who had received a payment from a pharmaceutical company said that they don’t feel that disclosing individual payments is necessary. A further 26 per cent said that doing so will negatively impact medical innovation.

The majority of healthcare professionals (75 per cent) said that disclosing payment information will have no impact on their relationships with pharmaceutical companies. On the other hand, 23 per cent of General Practitioners said that they would not be as likely to work with pharmaceutical companies in the future if their data is published. As well as GPs, 17 per cent of hospital specialists, 10 per cent of pharmacists and 6 per cent of nurses said the same.

The findings from the survey are revealed as pharmaceutical companies get ready to reveal payments and other ‘transfers of value’ to individual healthcare professionals and organisations during 2015. The data will be made public on the ABPI’s website from June 2016.

As well as this, the Health Secretary, Jeremy Hunt, is also making it compulsory from health professionals to declare any gifts they receive from pharmaceutical companies.

As part of the ‘Sunshine Rule’, which is set to be implemented next year, any NHS staff who do not declare any perks received from pharmaceutical companies may face being disciplines, dismissed or even sent to prison under the Bribery Act.

Both movements are being introduced as part of efforts to boost transparency within Europe.

Sign up for free insights from your sector…

Antispam code: 4645

Support Us..

We hope that you have found this article useful. This section is freely available for all to use. Please help support it by liking us or following us on our social media platforms:

Share this article..

For updated Pharmaceutical insights please follow us on @DJS_Pharma or use our RSS feed

Other Pharmaceutical Research Findings

Other Latest Market Research Insights

© DJS Research 2017